IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis - Junzhang Chen; Shiran Sun; Hui Li; Xiong Cai; Chidan Wan (Frontiers in Immunology, 2024)